We've found
12,064 Hematology
clinical trials
Hematology Clinical Trial
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of Kidney Tumors in Younger Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of Kidney Tumors in Younger Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of Kidney Tumors in Younger Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of Kidney Tumors in Younger Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of Kidney Tumors in Younger Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of Kidney Tumors in Younger Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Immunology / Infectious Diseases Clinical Trial
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Haemophilia A Clinical Trial
BAY81-8973 Pediatric Safety and Efficacy Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxysmal Nocturnal Hemoglobinuria Clinical Trial
Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry
Status: Enrolling
Updated: 1/11/2018
Click here to add this to my saved trials
Pediatric Acute Myelogenous Leukemia (AML) Clinical Trial
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Status: Enrolling
Updated: 12/6/2012
Click here to add this to my saved trials
Pediatric Acute Myelogenous Leukemia (AML) Clinical Trial
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Status: Enrolling
Updated: 12/6/2012
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 3/30/2018
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 5/5/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 5/5/2016
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
12,064 Hematology
clinical trials
Hematology Clinical Trial
Updated: 12/31/1969
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Updated: 12/31/1969
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Updated: 12/31/1969
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Updated: 12/31/1969
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Updated: 12/31/1969
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Updated: 12/31/1969
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Updated: 12/31/1969
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Study of Kidney Tumors in Younger Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Study of Kidney Tumors in Younger Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Study of Kidney Tumors in Younger Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Study of Kidney Tumors in Younger Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Study of Kidney Tumors in Younger Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Study of Kidney Tumors in Younger Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Haemophilia A Clinical Trial
Updated: 12/31/1969
BAY81-8973 Pediatric Safety and Efficacy Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
Updated: 12/31/1969
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
Updated: 12/31/1969
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxysmal Nocturnal Hemoglobinuria Clinical Trial
Updated: 1/11/2018
Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry
Status: Enrolling
Updated: 1/11/2018
Click here to add this to my saved trials
Pediatric Acute Myelogenous Leukemia (AML) Clinical Trial
Updated: 12/6/2012
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Status: Enrolling
Updated: 12/6/2012
Click here to add this to my saved trials
Pediatric Acute Myelogenous Leukemia (AML) Clinical Trial
Updated: 12/6/2012
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Status: Enrolling
Updated: 12/6/2012
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 3/30/2018
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 3/30/2018
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 4/24/2017
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Updated: 2/5/2018
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 7/27/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 7/27/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 7/27/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 5/5/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 5/5/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 5/5/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 5/5/2016
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Updated: 12/31/1969
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Updated: 12/31/1969
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Updated: 12/31/1969
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials